145 related articles for article (PubMed ID: 19952746)
1. Angiogenesis inhibitors in the management of breast cancer.
Bossung V; Harbeck N
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):79-86. PubMed ID: 19952746
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
Ademuyiwa FO; Miller KD
Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
Morabito A; Sarmiento R; Bonginelli P; Gasparini G
Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
[TBL] [Abstract][Full Text] [Related]
4. Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy.
Tonra JR; Hicklin DJ
Immunol Invest; 2007; 36(1):3-23. PubMed ID: 17190647
[TBL] [Abstract][Full Text] [Related]
5. New treatment approaches in renal cell carcinoma.
Facchini G; Perri F; Caraglia M; Pisano C; Striano S; Marra L; Fiore F; Aprea P; Pignata S; Iaffaioli RV
Anticancer Drugs; 2009 Nov; 20(10):893-900. PubMed ID: 19752718
[TBL] [Abstract][Full Text] [Related]
6. The present and future of angiogenesis-directed treatments of colorectal cancer.
O'Dwyer PJ
Oncologist; 2006 Oct; 11(9):992-8. PubMed ID: 17030640
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic strategies in breast cancer management.
Giovannini M; Aldrighetti D; Zucchinelli P; Belli C; Villa E
Crit Rev Oncol Hematol; 2010 Oct; 76(1):13-35. PubMed ID: 20702105
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice?
Mancuso A; Sternberg CN
Crit Rev Oncol Hematol; 2005 Jul; 55(1):67-81. PubMed ID: 15890525
[TBL] [Abstract][Full Text] [Related]
9. The potential of antiangiogenic therapy in non-small cell lung cancer.
Giaccone G
Clin Cancer Res; 2007 Apr; 13(7):1961-70. PubMed ID: 17404076
[TBL] [Abstract][Full Text] [Related]
10. Renal cell cancer.
Hutson TE; Figlin RA
Cancer J; 2007; 13(5):282-6. PubMed ID: 17921725
[TBL] [Abstract][Full Text] [Related]
11. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
12. Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions.
Gasparini G; Longo R; Fanelli M; Teicher BA
J Clin Oncol; 2005 Feb; 23(6):1295-311. PubMed ID: 15718328
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors.
Tandle A; Libutti SK
Clin Adv Hematol Oncol; 2003 Jan; 1(1):41-8. PubMed ID: 16227959
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.
Del Bufalo D; Ciuffreda L; Trisciuoglio D; Desideri M; Cognetti F; Zupi G; Milella M
Cancer Res; 2006 Jun; 66(11):5549-54. PubMed ID: 16740688
[TBL] [Abstract][Full Text] [Related]
16. Target-based therapies in breast cancer: current status and future perspectives.
Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
[TBL] [Abstract][Full Text] [Related]
17. The interaction of radiation therapy and antiangiogenic therapy.
O'Reilly MS
Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic therapy in the management of breast cancer.
Wu Y; Sun WL; Feng JF
Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270
[TBL] [Abstract][Full Text] [Related]
19. [Antiangiogenic agents and gastrointestinal cancers].
Lièvre A; Landi B; Mitry E; Taïeb J
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):504-20. PubMed ID: 18472378
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic drugs in oncology: a focus on drug safety and the elderly - a mini-review.
Boehm S; Rothermundt C; Hess D; Joerger M
Gerontology; 2010; 56(3):303-9. PubMed ID: 19940466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
